Gland Pharma Limited (GLAND.NS)
INR 1426.3
(2.34%)
INR 1426.3
(2.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 16.45 Billion INR | 11.77% |
| 2022 | 8.84 Billion INR | -36.83% |
| 2021 | 14 Billion INR | 16.34% |
| 2020 | 12.03 Billion INR | 39.79% |
| 2019 | 8.6 Billion INR | 37.88% |
| 2018 | 6.24 Billion INR | 36.27% |
| 2017 | 4.58 Billion INR | -17.87% |
| 2016 | 5.57 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.72 Billion INR | -35.19% |
| 2024 Q2 | 2.03 Billion INR | 17.86% |
| 2023 FY | 9.88 Billion INR | 11.77% |
| 2023 Q2 | 2.95 Billion INR | 29.43% |
| 2023 Q3 | 2.88 Billion INR | -2.53% |
| 2023 Q1 | 2.28 Billion INR | 101.7% |
| 2023 Q4 | 2.66 Billion INR | -7.76% |
| 2022 Q1 | 2.35 Billion INR | -25.97% |
| 2022 FY | 8.84 Billion INR | -36.83% |
| 2022 Q4 | 1.13 Billion INR | -63.84% |
| 2022 Q3 | 3.13 Billion INR | -3.79% |
| 2022 Q2 | 3.25 Billion INR | 38.63% |
| 2021 FY | 14 Billion INR | 16.34% |
| 2021 Q4 | 3.17 Billion INR | -1.13% |
| 2021 Q3 | 3.21 Billion INR | -8.39% |
| 2021 Q2 | 3.5 Billion INR | -14.72% |
| 2021 Q1 | 4.11 Billion INR | 35.63% |
| 2020 Q1 | 3.88 Billion INR | 78.72% |
| 2020 Q2 | 2.93 Billion INR | -24.49% |
| 2020 Q3 | 2.39 Billion INR | -18.45% |
| 2020 FY | 12.03 Billion INR | 39.79% |
| 2020 Q4 | 3.03 Billion INR | 26.65% |
| 2019 FY | 8.6 Billion INR | 37.88% |
| 2019 Q4 | 2.17 Billion INR | 15.92% |
| 2019 Q3 | 1.87 Billion INR | 0.0% |
| 2019 Q1 | 2.4 Billion INR | 0.0% |
| 2018 FY | 6.24 Billion INR | 36.27% |
| 2017 FY | 4.58 Billion INR | -17.87% |
| 2016 FY | 5.57 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott India Limited | 13.79 Billion INR | -19.267% |
| Cipla Limited | 105.7 Billion INR | 84.437% |
| GlaxoSmithKline Pharmaceuticals Limited | 13.6 Billion INR | -20.951% |
| Kopran Limited | 675.44 Million INR | -2335.679% |
| Marksans Pharma Limited | 7.79 Billion INR | -111.147% |
| NGL Fine-Chem Limited | 416.27 Million INR | -3852.166% |
| Pfizer Limited | 9.61 Billion INR | -71.163% |
| Sanofi India Limited | 12.19 Billion INR | -34.928% |
| SMS Pharmaceuticals Limited | 1.34 Billion INR | -1127.607% |
| TTK Healthcare Limited | 249.89 Million INR | -6483.585% |